Max Salm
Senior Director, Target Sciences at Bicycle Therapeutics
London, England, United Kingdom
Summary
👤
Senior🎓
Top SchoolMax Salm is a senior leader in computational and molecular biology with over a decade driving genomics-enabled therapy development across pharma and biotech. He combines a PhD from Imperial College London with hands-on expertise in immunotherapy, clinical genomics and biomarker discovery, contributing first-author papers in Science and Nature Genetics and amassing 6,000+ citations. At Achilles Therapeutics he led bioinformatics teams building the PELEUS™ platform for personalized neoantigen T-cell therapies and now directs target sciences at Bicycle Therapeutics. His strengths span large-scale sequencing, structural variant and clonality analysis, and machine learning applied in HPC environments to accelerate translational programs. Colleagues describe him as an interdisciplinary problem-solver who turns complex genomic signals into robust, clinically actionable algorithms. Unusually for his level, he retains deep technical involvement in algorithm design and benchmarking alongside strategic leadership.
9 years of coding experience
14 years of employment as a software developer
PhD Clinical Medicine (Computational & Molecular Biology Human Genetics), PhD Clinical Medicine (Computational & Molecular Biology Human Genetics) at Imperial College LondonBSc (Hons) Biology, BSc (Hons) Biology at University of Bristol
English, German, Spanish, French, r, python, processing
Github Skills (9)
bam4
sequencing4
classification3
testing3
bioinformatics3
mutation2
mutation-testing2
rna-seq1
sequence1
Programming languages (2)
Github contributions (5)
MaxSalm/varSLR
May 2017 - May 2017
Contributions:2 commits, 1 push, 1 branch in 1 day
MaxSalm/pdxBlacklist
Mar 2017 - Mar 2017
Contributions:1 branch in 1 day
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.